Showing 5,721 - 5,740 results of 26,312 for search '(( 5 ((ng decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 0.89s Refine Results
  1. 5721

    Discovery of Novel 3‑Phenylpiperidine Derivatives Targeting the β‑Catenin/B-Cell Lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD‑1 Antibody for the Tre... by Hao Zhang (15339)

    Published 2023
    “…Among them, compound <b>41</b> showed the best IC<sub>50</sub> (0.72 μM) in a competitive fluorescence polarization assay and a <i>K</i><sub>D</sub> value of 0.26 μM for the β-catenin protein. …”
  2. 5722
  3. 5723

    Severity of anaemia status among pregnant women. by Donatus Nbonibe Abaane (15909683)

    Published 2023
    “…At 36 weeks, AIP prevalence was 44.8% (95%CI:39.2, 50.4) using a cut-off of 11.0g/dl. At p<0.05, registering after the first trimester (AOR = 1.87, 95%CI: 1.17, 2.98, P = 0.009) and at a regional hospital (AOR = 2.25, 95%CI: 1.02, 4.98, P = 0.044) were associated with increased odds of AIP but registering at a private hospital (AOR = 0.32, 95%CI: 0.11, 0.92, P = 0.035) was associated with decreased odds of AIP at booking. …”
  4. 5724
  5. 5725

    PPM1A facilitates both nuclear distribution and transcription potency of YAP/TAZ. by Ruyuan Zhou (10197187)

    Published 2021
    “…<b>(B–D)</b> Transcription potency of YAP (5 ng), which was suppressed by coexpression of MST1 (50 ng) (B), LATS1 (500 ng) (C), or MAP4K1 (50 ng) (D), was markedly recovered by cotransfection of wild-type PPM1A but not the enzyme-dead PPM1A (D239N). …”
  6. 5726
  7. 5727
  8. 5728
  9. 5729
  10. 5730
  11. 5731

    Table_1_Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a... by Arthur Allignol (4017428)

    Published 2021
    “…</p><p>Results: Of the 5,340 patients included in the analysis, there was a high proportion of patients free from relapse across all age groups (range: 94.1–95.4%), with a numerical decrease in the number of MRI performed by age (mean: 0.25, 18–30 years; 0.20, 31–40 years; 0.16, 41–50 years; 0.14, ≥51 years). …”
  12. 5732

    Table_1_Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a... by Arthur Allignol (4017428)

    Published 2021
    “…</p><p>Results: Of the 5,340 patients included in the analysis, there was a high proportion of patients free from relapse across all age groups (range: 94.1–95.4%), with a numerical decrease in the number of MRI performed by age (mean: 0.25, 18–30 years; 0.20, 31–40 years; 0.16, 41–50 years; 0.14, ≥51 years). …”
  13. 5733
  14. 5734
  15. 5735
  16. 5736
  17. 5737
  18. 5738
  19. 5739
  20. 5740